“…Today, the differentiation between C. neoformans and C. gattii is a difficult task since: the available commercial differentiation methods (e.g., API ® 20C AUX [bioMérieux, France], Vitek ® [bioMérieux] and MicroScan ® [Siemens, Germany]) do not differentiate between C. neoformans and C. gattii; and the methods capable of differentiating the two species (multiplex PCR, liquid array detection of pathogens, PCR restriction fragment length polymorphism [12,13] and matrix-assisted laser desorption/ionization mass spectrometry future science group of continental North America. The potential for C. gattii to cause illness in immunocompetent patients and its rapid spread worldwide justify the implementation of a public health effort to increase the awareness of both the public and healthcare professionals [1,[18][19][20][21][22][23][24]. The mechanism of C. gattii dispersion is not well understood.…”